05 May 2009

Hepatocellular Carcinoma: Screening, Diagnosis, and Treatment



Hepatocellular Carcinoma: Screening, Diagnosis, and Treatment
Presentation lecture by: Catherine Frenette, MD
California Pacific Medical Center
The Barry S. Levin Department of Transplantation


Hepatocellular Carcinoma
Increasing prevalence of patients with cirrhosis
Regional Variations in HCC-related Mortality
Risk Factors for HCC
Chronic Hepatitis
Cirrhosis
HCC
Chronic HBV Infection
Inactive Carrier State
Chronic Hepatitis
Clinical Outcome of Chronic Hepatitis B
HCC Epidemiology
HBV DNA Associated with Increased Risk of HCC
Primary Prevention of HCC
Surveillance Recommendations
Surveillance for HCC Prolongs Survival
Cost-Effectiveness of HCC Surveillance
Quad Phase Imaging of Hepatocellular Carcinoma
Liver transplantation
Curative treatments
Randomized controlled trials
HCC: Barcelona Clinic Liver Cancer
Staging Classification
Factors Determining Prognosis of Hepatocellular Cancer
Management of Hepatocellular Carcinoma
Newer modalities
Surgical Resection: Indications
Liver Transplantation
UNOS Criteria for Liver Transplantation for HCC
Liver Transplantation for HCC
Months After Transplantation Patients at Risk
Liver Transplantation for HCC: Outcomes Applying Milan Criteria
Liver Transplantation for HCC UCSF Criteria
Differentiated histology
Local Ablation Therapy for Transplant Candidates
Trans-Arterial Chemoembolization TACE
Catheter-Based Therapies
TACE for HCC
Radiofrequency Ablation
RFA Modalities
RFA Indications
RFA Contraindications
RFA Complications
Radiographic Outcomes
New Therapies Under Investigation
Chemotherapy

* Sorafenib* (Nexavar)
* Erlotinib (Tarceva)
* Sirolimus (Rapamune)
* Capecitabine (Xeloda)
* Floxuridine (FUDR)
* Bevacizumab (Avastin)
* Sargramostim (Leukine)
* Oxaliplatin (Eloxatin)
* Imatinib (Gleevac)
Local Therapy
Yttrium-90 Microspheres
Doxorubicin Eluting Beads
Systemic chemotherapy
GI Intergroup Recommendations
Macrovascular invasion or Metastases
Supportive Care
Conclusion

* Screening saves lives
* Resection or Transplantation best option
* RFA used for unifocal lesions < 5 cm
* TACE used for multifocal, lesions > 5 cm
o Non surgical candidates
* Combination therapies
o TACE and RFA
* New Strategies
o Yttrium-90 theraspheres
o Drug Eluting microspheres
* Sorafenib used when local treatment not an option


Hepatocellular Carcinoma: Screening, Diagnosis, and Treatment.ppt

0 comments:

All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by Ourblogtemplates.com 2008

Back to TOP